FDA rejects Multiple Sclerosis drug Cladribine application as 'incomplete'
U.S. regulators rejected as incomplete Merck KGaA's application to sell the oral treatment multiple sclerosis. Merck, the German based drugmaker will seek a meeting with the U.S. Food and Drug Administration after the agency refused to accept i...ts application for the medicine, cladribine, spokesman Gangolf Schrimpf said.......
More - http://www.msrc.co.uk/index.cfm?fuseact ... ageid=1629
FDA rejects Multiple Sclerosis drug Cladribine application
Bummer. I hope it doesn't take them too long to sort it out.
I also hope Novartis does better with their app for Fingolimod. Novartis said they had been in contact with the FDA throughout the later stages of the trial, so I hope their application is complete and doesn't delay the review. They're supposed to file before the end of this year.
I also hope Novartis does better with their app for Fingolimod. Novartis said they had been in contact with the FDA throughout the later stages of the trial, so I hope their application is complete and doesn't delay the review. They're supposed to file before the end of this year.
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2005 Views
-
Last post by frodo
-
- 0 Replies
- 1854 Views
-
Last post by frodo
-
- 1 Replies
- 2048 Views
-
Last post by frodo
-
- 0 Replies
- 1849 Views
-
Last post by frodo
-
- 0 Replies
- 1179 Views
-
Last post by frodo
-
- 0 Replies
- 1500 Views
-
Last post by frodo
-
- 0 Replies
- 3941 Views
-
Last post by frodo
-
- 0 Replies
- 2584 Views
-
Last post by frodo
-
- 0 Replies
- 2180 Views
-
Last post by NHE